Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study (Q80470628)
Jump to navigation
Jump to search
scientific article published on 13 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study |
scientific article published on 13 June 2007 |
Statements
Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study (English)
Sayeeda Rahman
Aziz Al-Shafi Ismail
Shaiful Bhari Ismail
Nyi Nyi Naing
Abdul Rashid Abdul Rahman
13 June 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference